Asia Pacific hosts 50 percent of the world’s new cancer cases each year, and deaths caused by cancer in Asia are expected to increase by 36 percent by 2030. Asia Pacific has the world’s highest incidence of liver and stomach cancers, and prostate cancer is now one of the leading male cancers in some Asian countries. Like other parts of the world, blood cancer remains rare in Asia but equally burdened with a limited range of treatment options.

We aim to transform cancer to a preventable, chronic or curable disease by delivering innovative diagnostic and therapeutic solutions that prolong and improve patients’ lives and fight the devastation of cancer.